CNMD Logo

CONMED Corporation (CNMD) 

NYSE
Market Cap
$2.33B
Sector
Healthcare
Industry
Medical—Devices
Rank in Sector
134 of 776
Rank in Industry
14 of 100

Largest Insider Buys in Sector

CNMD Stock Price History Chart

CNMD Stock Performance

About CONMED Corporation

CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for surgical procedures worldwide. It offers orthopedic surgery products, including TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and PopLok Knotless Suture Anchors, which provide unique clinical solutions to orthopedic surgeons for the repair of soft tissue injuries, as well as supporting products that enable surgeons to perform minimally invasive sports medicine surgeries. The …

Insider Activity of CONMED Corporation

Over the last 12 months, insiders at CONMED Corporation have bought $544,054 and sold $662,987 worth of CONMED Corporation stock.

On average, over the past 5 years, insiders at CONMED Corporation have bought $461,291 and sold $19.9M worth of stock each year.

Highest buying activity among insiders over the last 12 months: Aronson Martha Goldberg (director) — $283,920. Beyer Pat (Chief Operating Officer) — $204,900. Schwarzentraub Barbara J (director) — $99,873.

The last purchase of 1,350 shares for transaction amount of $97,322 was made by BRONSON DAVID M (director) on 2024‑05‑13.

List of Insider Buy and Sell Transactions, CONMED Corporation

2024-06-14SalePresident AS and AET
4,000
0.0125%
$71.82$287,280-3.98%
2024-05-13Purchasedirector
1,350
0.0043%
$72.09$97,322-2.31%
2024-05-08Purchasedirector
1,442
0.0047%
$69.26$99,873+2.52%
2024-05-06Purchasedirector
2,000
0.0065%
$70.98$141,960+0.58%
2024-04-30PurchaseChief Operating Officer
3,000
0.0098%
$68.30$204,900+4.60%
2023-12-04SalePresident AS and AET
2,300
0.0074%
$109.93$252,833-32.27%
2023-11-07SalePresident AS and AET
1,200
0.004%
$102.39$122,874-24.51%
2023-09-13SalePresident AS and AET
2,000
0.0065%
$107.31$214,629-24.30%
2023-08-16SaleExecutive Vice President & CFO
1,355
0.0045%
$112.00$151,760-20.67%
2023-06-15SalePresident, CEO and Chair
1,000
0.0033%
$136.00$136,000-27.06%
2023-06-08SaleExecutive Vice President - HR
1,700
0.0056%
$131.81$224,077-23.53%
2023-06-08SaleVP GM Advanced Surgery
5,000
0.0163%
$131.14$655,676-23.53%
2023-06-07Saledirector
812
0.0027%
$129.01$104,756-21.15%
2023-05-22SaleVP GM Advanced Surgery
1,500
0.0049%
$120.89$181,343-13.77%
2023-05-18SaleVP GM Advanced Surgery
1,500
0.0049%
$119.24$178,861-10.93%
2023-05-01Saledirector
2,072
0.0067%
$125.00$259,000-14.52%
2023-04-28SaleTreasurer and VP, Tax
8,717
0.0288%
$126.53$1.1M-14.28%
2023-04-28SaleSpecial Counsel & Corp Secy
10,000
0.0329%
$126.10$1.26M-14.28%
2023-04-28SaleEVP, STRAT & CORP DEVT
2,442
0.0082%
$128.00$312,576-14.28%
2023-04-28SaleTreasurer and VP, Tax
24,017
0.0792%
$126.38$3.04M-14.28%

Insider Historical Profitability

8.16%
BRONSON DAVID Mdirector
16460
0.0533%
$75.5520<0.0001%
Beyer PatChief Operating Officer
10807
0.035%
$75.5522<0.0001%
Aronson Martha Goldbergdirector
2000
0.0065%
$75.5510
Schwarzentraub Barbara Jdirector
1442
0.0047%
$75.5511
SHALLISH ROBERT D JREVP, Finance, CFO
53915
0.1745%
$75.55212+8.79%

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
BlackRock$409.65M16.615.12M+1.68%+$6.77M0.01
The Vanguard Group$276.82M11.223.46M+1.08%+$2.95M0.01
EARNEST Partners$189.88M7.72.37M+1.08%+$2.03M0.87
Capital Research Global Investors$116.98M4.741.46M-47.02%-$103.81M0.03
Champlain Investment Partners, LLC$104.35M4.231.3M+36.12%+$27.69M0.6
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.